Stories
Stories
In the UK, She Leads the Search for a COVID Vaccine
When she was asked to chair the UK’s Vaccine Taskforce back in May, Kate Bingham (MBA 1991) paused. Despite nearly three decades of experience as a life sciences investor with SV Health Investors, the enormity of leading her country’s effort to put a stop to the spread of COVID-19 was daunting. “When I told my daughter I wasn’t sure I could do this, she looked at me and said, ‘Mum! If I’d said that you’d have given me all this lip about ‘don’t be under-confident, you’re just putting yourself down!’ So I was told off by my 22-year-old,” Bingham told the Daily Mail.
In fact, Bingham’s role—working with pharmaceutical firms, planning manufacturing facilities, and making investment decisions—ties in directly with her career experience. “As a venture capitalist, I have to write a personal check into every single thing I invest my investors’ money in,” she explains. “So they want us personally on the hook with skin in the game for everything we do. That sort of approach is actually what you need in this case. It’s government money, not my money, but the mentality is the same.”
Bingham, who grew up in London and studied biochemistry at Oxford University, is also making a plan for when a vaccine does become available. While a small portion of the UK population is staunchly “anti-vax” her primary concern is those who are fearful of how quickly the vaccine is being developed. “The safety of the clinical trials is not being compromised,” she said. “Vaccine hesitancy is something we need to address, especially in ethnic minority communities who tend not to sign up for vaccine trials. So that’s been a big push in what we’ve been doing with the vaccine registry.”
Post a Comment
Related Stories
-
- 15 Dec 2024
- HBS Magazine
After Ozempic
Re: Kate Mulroney (MBA 1984); Joseph L. Badaracco (John Shad Professor of Business Ethics); By: Jen McFarland Flint; Illustrations by Pete Ryan -
- 01 Mar 2024
- HBS Alumni Bulletin
On the Radar
Re: Matthew McKnight (MBA 2012); By: Janine White -
- 01 Jun 2023
- HBS Alumni Bulletin
Research Brief: The Best Medicine
Re: Joshua R. Schwartzstein (Cahners-Rabb Professor of Business Administration); By: Jen McFarland Flint -
- 22 Feb 2022
- HBS Alumni Bulletin
Elevator Pitch: Good Vibrations
Re: Laura Yecies (MBA 1988)
Stories Featuring Kate Bingham
-
- 26 Jan 2021
- HBS Clubs
Clubs See Wealth in FemTech; Health Care Alumni Look at COVID Response
Re: Linda Greub (MBA 1987); Stasia Obremskey (MBA 1987); Alice Zheng (MBA 2014); Rachel Brannan (MBA 1987); Corinne Nevinny (MBA 1987); Heather Myers (MBA 1992); Paul Mango (MBA 1988); Kate Bingham (MBA 1991); Pete Stebbins (MBA 1991); By: Margie Kelley -
- 24 Sep 2020
- HBS Alumni Bulletin
The Race for a Vaccine
Re: Stefan Bancel (MBA 2000); Kate Bingham (MBA 1991); Gary P. Pisano (Harry E. Figgie, Jr. Professor of Business Administration (Leave of Absence)); By: April White